文献速递消化道肿瘤与早癌消化内镜

胃腺瘤内镜下切除后胃癌发病率与死亡率:一项全国性队列研究

Gastric Cancer Incidence and Mortality After Endoscopic Resection of Gastric Adenoma: A Nationwide Cohort Study.
PubMed 文献 · Am J Gastroenterol · 2023-08-23

该研究基于韩国全国数据库联动,纳入2011至2013年间切除胃腺瘤的44,405例患者,中位随访8.4年。与一般人群相比,胃癌发生率高于预期(标化发病比1.98),但胃癌死亡率低于预期(标化死亡比0.50);与非腺瘤对照组相比,腺瘤切除患者胃癌风险(HR 2.84)及死亡风险(HR 1.66)均更高。

要点

  • 胃腺瘤切除后胃癌发生风险仍高于一般人群,标化发病比1.98(95%CI 1.84-2.13)。
  • 胃腺瘤切除后胃癌死亡风险低于一般人群,标化死亡比0.50(95%CI 0.40-0.60)。
  • 与非腺瘤对照组相比,腺瘤切除患者胃癌风险HR 2.84(95%CI 2.51-3.21)。

核心结论

  • 胃腺瘤切除后胃癌死亡率低于一般人群预期,但胃癌发生率高于一般人群预期。
  • 分析提示胃腺瘤切除后随访策略的重要性。

研究设计与样本

  • 研究利用全国数据库联动,评估2011至2013年间在韩国切除胃腺瘤患者的胃癌发生率与死亡率。
  • 主要与韩国一般人群比较,估算标化发病比与标化死亡比。
  • 次要与非腺瘤对照组(经食管胃十二指肠镜检查无胃肿瘤、按年龄、性别和日历年匹配)比较,用Cox比例风险模型计算风险比(HR)。
  • 共纳入44,405例腺瘤切除患者,非腺瘤队列39,826例。

主要发现

  • 中位随访8.4年期间,1,038例(2.34%)腺瘤切除患者被诊断为胃癌,预期524例,标化发病比1.98(95%CI 1.84-2.13)。
  • 预期胃癌死亡199例,实际观察99例,标化死亡比0.50(95%CI 0.40-0.60)。
  • 与非腺瘤队列相比,腺瘤切除患者胃癌风险更高(HR 2.84;95%CI 2.51-3.21)。
  • 与非腺瘤队列相比,腺瘤切除患者胃癌相关死亡风险更高(HR 1.66;95%CI 1.19-2.31)。

临床怎么用

  • 作者认为,分析结果提示胃腺瘤切除后随访策略的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Gastric adenoma is a precursor lesion of gastric cancer. We investigated whether the removal of gastric adenoma prevented gastric cancer incidence and its mortality. METHODS: Using the linkage of nationwide databases, we assessed gastric cancer incidence and mortality among patients who had gastric adenomas removed between 2011 and 2013 in Korea. These outcomes were compared primarily with those of the Korean general population by estimating the standardized incidence and mortality ratio and secondarily with internal control subjects who did not have gastric neoplasm after esophagogastroduodenoscopy and were matched for age, sex, and calendar year by calculating hazard ratios (HR) with the Cox proportional hazards model. RESULTS: We identified 44,405 adenoma removal patients. During a median follow-up of 8.4 years, 1,038 (2.34%) of them were given a diagnosis of gastric cancer and a total of 524 gastric cancers were expected for a standard incidence ratio of 1.98 (95% confidence interval [CI], 1.84-2.13). A total of 199 deaths from gastric cancer were expected and 99 were observed for a standard mortality ratio of 0.50 (95% CI, 0.40-0.60). Compared with the nonadenoma cohort (n = 39,826), the adenoma removal patients had a higher risk of gastric cancer (HR, 2.84; 95% CI, 2.51-3.21) and associated mortality (HR, 1.66; 95% CI, 1.19-2.31). DISCUSSION: Removal of gastric adenoma resulted in lower-than-expected mortality but higher-than-expected incidence due to gastric cancer than that in the general population. Our analyses indicated the importance of follow-up strategy after removal of gastric adenoma.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Park JM, Cho S, Shin GY, et al. Gastric Cancer Incidence and Mortality After Endoscopic Resection of Gastric Adenoma: A Nationwide Cohort Study. Am J Gastroenterol. 2023. PMID: 37610029. doi:10.14309/ajg.0000000000002484

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。